General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Under the leadership of Joseph Jimenez, the Novartis Executive Committee is responsible for overseeing the business operations of Group companies.

Joseph Jimenez, Chief Executive Officer (CEO)
Joseph Jimenez, Chief Executive Officer (CEO)
Juergen Brokatzky, Head of Human Resources
Juergen Brokatzky, Head of Human Resources
Kevin Buehler, Division Head, Alcon
Kevin Buehler, Division Head, Alcon
Felix Ehrat, Ph.D., General Counsel
Felix Ehrat, Ph.D., General Counsel
David Epstein, Division Head, Novartis Pharmaceuticals
David Epstein, Division Head, Novartis Pharmaceuticals
Mark C. Fishman, M.D., President of the Novartis Institutes for BioMedical Research
Mark C. Fishman, M.D., President of the Novartis Institutes for BioMedical Research
Jeff George, Division Head, Sandoz
Jeff George, Division Head, Sandoz
George Gunn, Division Head, Novartis Animal Health, Head of Novartis Corporate Responsibility
George Gunn, Division Head, Novartis Animal Health, Head of Novartis Corporate Responsibility
Harry Kirsch, Chief Financial Officer
Harry Kirsch, Chief Financial Officer
Brian McNamara, Division Head, Novartis OTC
Brian McNamara, Division Head, Novartis OTC
Andrin Oswald, Division Head, Novartis Vaccines and Diagnostics
Andrin Oswald, Division Head, Novartis Vaccines and Diagnostics

You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).